{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:29:54Z","timestamp":1791804594166,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270228"],"award-info":[{"award-number":["82270228"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82350105"],"award-info":[{"award-number":["82350105"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["2024YXXLHGG009"],"award-info":[{"award-number":["2024YXXLHGG009"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park","doi-asserted-by":"publisher","award":["Z251100006025002"],"award-info":[{"award-number":["Z251100006025002"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20250484986"],"award-info":[{"award-number":["20250484986"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012492","name":"Beijing Municipal Outstanding Young Talents","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["Z240019"],"award-info":[{"award-number":["Z240019"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.canlet.2026.218329","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:16:55Z","timestamp":1771431415000},"page":"218329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Prognostic significance of HLA-B leader matching status and its relationship with NK cell reconstitution in patients with hematological malignancies following haploidentical transplantation"],"prefix":"10.1016","volume":"644","author":[{"given":"Ming-Hao","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ju","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Xing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8139-1773","authenticated-orcid":false,"given":"Xiang-Yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218329_bib1","first-page":"562","article-title":"Optimization of T-cell-replete haploidentical hematopoietic stem cell transplantation: the Chinese experience","volume":"110","author":"Mo","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2026.218329_bib2","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1038\/s41409-024-02419-8","article-title":"Hematopoietic stem cell transplantation activity in China 2022-2023. The proportions of peripheral blood for stem cell source continue to grow: a report from the Chinese blood and marrow transplantation registry group","volume":"59","author":"Xu","year":"2024","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.canlet.2026.218329_bib3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41409-025-02524-2","article-title":"The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT","volume":"60","author":"Passweg","year":"2025","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.canlet.2026.218329_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41409-018-0239-9","article-title":"Haploidentical versus matched donor stem cell transplantation for patients with hematological malignancies: a systemic review and meta-analysis","volume":"54","author":"Yang","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.canlet.2026.218329_bib5","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1182\/blood-2015-02-627786","article-title":"Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218329_bib6","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1182\/bloodadvances.2024013853","article-title":"Haploidentical vs HLA-matched sibling donor HCT with PTCy prophylaxis: HLA factors and donor age considerations","volume":"8","author":"Mehta","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2026.218329_bib7","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1182\/blood-2011-07-338822","article-title":"Haploidentical hematopoietic transplantation: current status and future perspectives","volume":"118","author":"Reisner","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218329_bib8","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood.2021013443","article-title":"HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide","volume":"139","author":"Fuchs","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218329_bib9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1399-0012.2011.01499.x","article-title":"The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation","volume":"26","author":"Huo","year":"2012","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.canlet.2026.218329_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/tan.15022","article-title":"HLA-B leader genotypes in a clinical population","volume":"102","author":"Balgansuren","year":"2023","journal-title":"HLA"},{"key":"10.1016\/j.canlet.2026.218329_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aag1672","article-title":"Class I HLA haplotypes form two schools that educate NK cells in different ways","volume":"1","author":"Horowitz","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.canlet.2026.218329_bib12","doi-asserted-by":"crossref","first-page":"601 e1","DOI":"10.1016\/j.jtct.2022.06.023","article-title":"Lineage-Specific relapse prediction after haploidentical transplantation with post-transplant cyclophosphamide based on recipient HLA-B-Leader genotype and HLA-C-Group KIR ligand","volume":"28","author":"Solomon","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.canlet.2026.218329_bib13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41409-022-01842-z","article-title":"Impact of HLA-B leader matching on clinical outcomes after haploidentical transplantation using antithymocyte globulin-based conditioning","volume":"58","author":"Wang","year":"2023","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.canlet.2026.218329_bib14","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/bjh.14622","article-title":"Recipient-donor KIR ligand matching prevents CMV reactivation post-haploidentical T cell-replete transplantation","volume":"177","author":"Zhao","year":"2017","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2026.218329_bib15","first-page":"270","article-title":"Assessment of HLA-B genetic variation with an HLA-B leader tool and implications in clinical transplantation","volume":"6","author":"Sajulga","year":"2022","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2026.218329_bib16","first-page":"843","volume":"124","author":"Wang","year":"2014"},{"key":"10.1016\/j.canlet.2026.218329_bib17","first-page":"825","article-title":"Consensus conference on Acute GVHD grading","volume":"15","author":"Przepiorka","year":"1994","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.canlet.2026.218329_bib18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.canlet.2026.218329_bib19","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1182\/bloodadvances.2019000242","article-title":"Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation","volume":"3","author":"Zhao","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2026.218329_bib20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s10875-011-9630-7","article-title":"Immune reconstitution following unmanipulated HLA-mismatched\/haploidentical transplantation compared with HLA-identical sibling transplantation","volume":"32","author":"Chang","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.canlet.2026.218329_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jtct.2022.11.027","article-title":"HLA factors versus Non-HLA factors for haploidentical donor selection","volume":"29","author":"Mehta","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.canlet.2026.218329_bib22","first-page":"362","article-title":"HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation","volume":"136","author":"Petersdorf","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218329_bib23","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.3324\/haematol.2020.264424","article-title":"Use of the HLA-B leader to optimize cord blood transplantation","volume":"106","author":"Petersdorf","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2026.218329_bib24","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/S2352-3026(19)30208-X","article-title":"Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study","volume":"7","author":"Petersdorf","year":"2020","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.canlet.2026.218329_bib25","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/bjh.20035","article-title":"Indirect presentation of mismatched human leukocyte antigen-B associates with outcomes of cord blood transplantation","volume":"206","author":"Sugio","year":"2025","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2026.218329_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70206","article-title":"Immune reconstitution after haploidentical hematopoietic stem cell transplantation with different Non-T-Cell depletion protocols","volume":"6","author":"Ma","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.canlet.2026.218329_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1005031","article-title":"Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"13","author":"Mushtaq","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218329_bib28","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbmt.2007.12.497","article-title":"Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies","volume":"14","author":"Chang","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.canlet.2026.218329_bib29","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2018.02.023","article-title":"Early reconstitution of NK and gammadelta T cells and its implication for the design of post-transplant immunotherapy","volume":"24","author":"de Witte","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.canlet.2026.218329_bib30","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1038\/s41467-019-13032-5","article-title":"Synergized regulation of NK cell education by NKG2A and specific Ly49 family members","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218329_bib31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1182\/bloodadvances.2025017707","article-title":"Functional recovery of NK cells after T-cell replete haploidentical HSCT: delayed licensing and poor anti-acute myeloid leukemia activity","volume":"10","author":"Jullien","year":"2026","journal-title":"Blood Adv."},{"key":"10.1016\/j.canlet.2026.218329_bib32","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2010-04-282301","article-title":"CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset","volume":"116","author":"Lopez-Verges","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2026.218329_bib33","article-title":"Delayed NK cell reconstitution and reduced NK activity increased the risks of CMV disease in allogeneic-hematopoietic stem cell transplantation","volume":"21","author":"Park","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218329_bib34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11427-018-9565-5","article-title":"NK cell reconstitution following unmanipulated HLA-mismatched\/haploidentical transplantation compared with matched sibling transplantation","volume":"63","author":"Hu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.canlet.2026.218329_bib35","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3324\/haematol.2020.271445","article-title":"Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic myeloablative peripheral blood stem cell transplantation","volume":"107","author":"Massoud","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.canlet.2026.218329_bib36","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/sj.leu.2404892","article-title":"Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia","volume":"21","author":"Savani","year":"2007","journal-title":"Leukemia"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526000923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:07:36Z","timestamp":1777550856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526000923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"alternative-id":["S0304383526000923"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218329","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of HLA-B leader matching status and its relationship with NK cell reconstitution in patients with hematological malignancies following haploidentical transplantation","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218329"}}